✦ LIBER ✦
European ex-factory price development for global pharmaceutical companies in the context of the international price reference (ipr) framework. Impact of the german health care reform (amnog) on the european price development for innovative pharmaceuticals
✍ Scribed by Ernst, F.
- Book ID
- 122005510
- Publisher
- John Wiley and Sons
- Year
- 2013
- Tongue
- English
- Weight
- 71 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.